Skip to main content

$0.315 0.010 (3.28%)

High

$0.32

Low

$0.30

Trades

243

Turnover

$627,825

Volume

2,012,212
30 June 2023 at 4:10pm
Register to track IMM and receive email alerts.

Update on MBC trial design following successful FDA meeting

StockBot

416,823 posts

IMM released this announcement to the ASX on 23 December 2022, 13:00. The announcement is marked as price sensitive, and is 3 page(s) in length and 226.76kb in size.

You can view all announcements from IMM and see how they appear on a price chart on the announcements page.

At the date of this announcement, IMM was 0.617% short sold according to ASIC data. It was ranked the 281st most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).

Other Recent Announcements from IMM
Application for quotation of securities - IMM 29 June 2023, 10:09
US patent granted for Efti with PD-1 pathway inhibitor 27 June 2023, 14:37
Immutep completes underwritten retail entitlement offer 27 June 2023, 8:16
Update on MBC trial design following successful FDA meeting 23 December 2022, 13:00
Change of Director's Interest Notice L Turnbull 22 December 2022, 15:58
Change of Director's Interest Notice - P Meyers 22 December 2022, 15:56
Change of Director's Interest Notice - R Howard 22 December 2022, 15:54
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track IMM and receive email alerts.